Buspirone Treatment of Anxious AlcoholicsA Placebo-Controlled Trial
Henry R. Kranzler, MD;
Joseph A. Burleson, PhD;
Frances K. Del Boca, PhD;
Thomas F. Babor, PhD;
Patricia Korner, RN;
Joseph Brown, PhD;
Michael J. Bohn, MD
Arch Gen Psychiatry. 1994;51(9):720-731.
Abstract
Background
Symptoms of anxiety are common in alcoholics and may contribute to relapse following initiation of abstinence. Buspirone hydrochloride, a serotonin1A partial agonist, has a pharmacologic profile that may be particularly suited to the treatment of anxious alcoholics.
Methods
We conducted a randomized, 12-week, placebo-controlled trial of buspirone in 61 anxious alcoholics, all of whom also received weekly relapse prevention psychotherapy. Outcomes were measured at the end of treatment and at a 6-month follow-up evaluation.
Results
Buspirone therapy was associated with greater retention in the 12-week treatment trial, reduced anxiety, a slower return to heavy alcohol consumption, and fewer drinking days during the follow-up period.
Conclusions
Buspirone appears to have a useful role in the treatment of anxious alcoholics. Further research is needed to clarify which patient characteristics and concomitant treatments result in optimal response to buspirone therapy.
Author Affiliations
From the Alcohol Research Center, Department of Psychiatry, University of Connecticut Health Center, Farmington.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Review: A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)
Davidson et al.
J Psychopharmacol 2010;24:3-26.
ABSTRACT
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone
Martinotti et al.
J Psychopharmacol 2009;23:123-129.
ABSTRACT
Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
DO COMORBID ANXIETY DISORDERS IN ALCOHOL-DEPENDENT PATIENTS NEED SPECIFIC TREATMENT TO PREVENT RELAPSE?
Schade et al.
Alcohol Alcohol 2003;38:255-262.
ABSTRACT
| FULL TEXT
Treating anxiety complicated by substance misuse
Lingford-Hughes et al.
Adv. Psychiatr. Treat. 2002;8:107-116.
FULL TEXT
The Patient Recovering from Alcohol or Drug Addiction: Special Issues for the Anesthesiologist
May et al.
Anesth. Analg. 2001;92:1601-1608.
FULL TEXT
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt et al.
JAMA 1999;281:1318-1325.
ABSTRACT
| FULL TEXT
Addiction Medicine
Franklin
JAMA 1995;273:1656-1657.
ABSTRACT
|
